跳至主要内容
临床试验/ISRCTN95889329
ISRCTN95889329已完成未知

Post-operative Radiotherapy In Minimum-risk Elderly - Phase II

niversity of Edinburgh (UK)0 个研究点目标入组 1,326 人开始时间: 2005年8月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,326

研究概览

简要总结

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25637340 results 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36791159/ (added 16/02/2023)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Breast conserving surgery with a complete pathological excision margin of all invasive and non invasive cancer (a minimum of 1 mm on histological assessment)
  • 2. Histologically confirmed unilateral breast cancer of pathological size 3 cm or less
  • 3. Oestrogen receptor or progesterone receptor positive and treated with post-operative adjuvant endocrine therapy (patients who have been treated with pre-operative neo-adjuvant endocrine therapy can be included)
  • 4. No axillary node involvement on histological assessment
  • 5. Medically suitable to attend for all treatment and follow up
  • 6. Able and willing to give informed consent

排除标准

  • 1. Age younger than 65 years (date of issue of pathology results)
  • 2. Grade III cancer combined with lymphatic/vascular invasion
  • 3. Previous in situ or invasive carcinoma of either breast
  • 4. Current or previous malignancy, within the past 5 years, other than non-melanomatous skin cancer or carcinoma in situ of cervix

研究者

发起方
niversity of Edinburgh (UK)

相似试验